1. Home
  2. FORM vs SRRK Comparison

FORM vs SRRK Comparison

Compare FORM & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

N/A

Current Price

$73.24

Market Cap

6.5B

Sector

Technology

ML Signal

N/A

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$48.36

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FORM
SRRK
Founded
1993
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.2B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
FORM
SRRK
Price
$73.24
$48.36
Analyst Decision
Buy
Strong Buy
Analyst Count
11
18
Target Price
★ $144.70
$70.06
AVG Volume (30 Days)
★ 1.5M
1.5M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.89
N/A
Revenue
N/A
N/A
Revenue This Year
$33.84
N/A
Revenue Next Year
$24.66
$662.10
P/E Ratio
$43.33
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.65
$38.69
52 Week High
$160.27
$61.76

Technical Indicators

Market Signals
Indicator
FORM
SRRK
Relative Strength Index (RSI) 35.61 56.01
Support Level $69.88 $44.88
Resistance Level $103.93 $50.56
Average True Range (ATR) 6.86 2.95
MACD -0.09 0.48
Stochastic Oscillator 9.57 57.77

Price Performance

Historical Comparison
FORM
SRRK

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: